Universal vaccines: shifting to one for many or shooting too high too soon! (Q37919551)

25 August 2017

1 reference

title

Universal vaccines: shifting to one for many or shooting too high too soon! (English)

1 reference

25 August 2017

Mawieh Hamad

1 reference

25 August 2017

publication date

23 June 2011

1 reference

Acta Pathologica et Microbiologica Scandinavica

25 August 2017

published in

1 reference

25 August 2017

volume

119

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

565-573

1 reference

Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene family

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Pathogen escape from host immunity by a genome program for antigenic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Antigenic variation in vector-borne pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Universal vaccines: shifting to one for many

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Meeting the challenge of influenza pandemic preparedness in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Vaccination against colonizing bacteria with multiple serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Strategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating them

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Design and pre-clinical evaluation of a universal HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Massive peptide sharing between viral and human proteomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Vaccination and autoimmune disease: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Whole-genome random sequencing and assembly of Haemophilus influenzae Rd

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Structural definition of a conserved neutralization epitope on HIV-1 gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Attacking the flu: neutralizing antibodies may lead to 'universal' vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Fc receptor-mediated antiviral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Reverse vaccinology: a genome-based approach for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

The key role of genomics in modern vaccine and drug design for emerging infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Genome-based approaches to develop vaccines against bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Host-induced epidemic spread of the cholera bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Identification and characterization of Helicobacter pylori genes essential for gastric colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Influenza virus vaccine based on the conserved hemagglutinin stalk domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Universal influenza A vaccine: optimization of M2-based constructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

A "universal" human influenza A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

M2e-based universal influenza A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

A novel glyco-conjugate vaccine against fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Immunological reactivity of blood from healthy humans to the rAls3p-N vaccine protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Multivalent recombinant protein vaccine against coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Neisseria lactamica protects against experimental meningococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

A universal long-term flu vaccine may not prevent severe epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Natural selection on the influenza virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Vaccine-induced pathogen strain replacement: what are the mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Overcoming viral escape with vaccines that generate and display antigen diversity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

The many important facets of T-cell repertoire diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Philosophic objection to vaccination as a risk for tetanus among children younger than 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Mumps and the UK epidemic 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

The effect of opinion clustering on disease outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

The global eradication of poliomyelitis: progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

A global perspective on vaccine safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02776.X

10.1111/J.1600-0463.2011.02776.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference